Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Novo Nordisk Inc. Appoints Curtis G. Oltmans as Corporate Vice President and General Counsel, Legal and Quality Affairs

PRINCETON, N.J., Jan. 4, 2013 /PRNewswire/ -- Novo Nordisk Inc., a global healthcare company with 90 years of innovation and leadership in diabetes care, announced that Curtis G. Oltmans has been promoted to Corporate Vice President and General Counsel, Legal and Quality Affairs and joins the Company's U.S. executive team.

(Photo: http://photos.prnewswire.com/prnh/20130104/PH36992)
(Logo: http://photos.prnewswire.com/prnh/20110414/NY80976LOGO)

In his new role, Oltmans is responsible for strategy and initiatives in the areas of law, quality, intellectual property, grants and philanthropy for the company's business in North America.

Previously, as Vice President and Deputy General Counsel, Oltmans lead the Legal Affairs team. He was tapped in 2010 to lead Novo Nordisk's Native American Health Initiative, a project designed to build sustainable diabetes care and education programs with the   Rosebud Sioux Tribe in Rosebud, South Dakota.

"Curt has used his extensive knowledge of the pharmaceutical industry to make significant contributions during his tenure so far at Novo Nordisk," said Jerzy Gruhn, President, Novo Nordisk Inc.  "He has led our legal team through a number of significant milestones, along with overseeing an important social responsibility effort for the Native American community.  We look forward to his continued leadership as a part of the Executive Team."

Oltmans joined Novo Nordisk in June 2005.   Prior to joining Novo Nordisk, he held various positions in the legal department of Eli Lilly and Company (1992-2005), including positions based in Europe and the United States.  He worked as an associate at Shook, Hardy & Bacon in Kansas City, Missouri (1989-1992), as well as a visiting associate at Cameron McKenna (1988-1989) in London, UK.  He frequently speaks on topics concerning complex litigation and fraud and abuse. 

Oltmans earned a Bachelor of Arts in political science from the University of Nebraska in 1985 before going on the school's College of Law, where he was graduated with High Distinction in 1988.  He's active in the local community, serving on Board of Directors for the Boys & Girls Club of Trenton & Mercer County.

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com.  For more information about our US activities, follow us on Twitter at @NovoNordiskUS.

 

 

 

 

 

SOURCE Novo Nordisk Inc.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Tune into: a cloud mindset One of the tenets of the cloud religion is that it should be possible – through the use of intelligent software – to build reliable systems on top of unreliable hardware. Just like you can build reliable and affordable storage systems using RAID (...
DevOps has traditionally played important roles in development and IT operations, but the practice is quickly becoming core to other business functions such as customer success, business intelligence, and marketing analytics. Modern marketers today are driven by data and rely on many ...
A few weeks back, I wrote a post about getting ready to address a coworker's bad code. This sparked some conversation across various media, including the following interesting question: ...seems that there is a breakdown in managing the development process. Why is Bob allowed [to kee...
Listen closely to the background hum of any agile shop, and you'll likely hear this ongoing chant: Automate! Automate! Automate! While automation can be incredibly valuable to the agile process, there are some key things to keep in mind when it comes to automated performance testing. ...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE